Echo Street Capital Management’s Haemonetics HAE Stock Holding History

Echo Street Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,819	Closed	-$325K	–	516
2023 Q2	$325K	Buy	3,819 +262	+7%	+$22.2K	﹤0.01%	367
2023 Q1	$294K	Sell	3,557 -6,731	-65%	-$545K	﹤0.01%	382
2022 Q4	$809K	Buy	+10,288	New	+$827K	0.01%	190
2021 Q2	–	Sell	-2,148	Closed	-$238K	–	649
2021 Q1	$238K	Buy	+2,148	New	+$266K	﹤0.01%	464

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Echo Street Capital Management's HAE Position: Q3 2023 in Review

Echo Street Capital Management sold out of Haemonetics (HAE) in Q3 2023, closing a stake of 3,819 shares — an estimated $325K sold.

Echo Street Capital Management first reported a position in HAE in Q1 2021 and held it in 4 quarters. The position peaked at $809K in Q4 2022. 296 funds tracked by Wall St. Rank hold HAE as of Q3 2023.

Echo Street Capital Management reported no remaining Haemonetics position as of Q3 2023 after selling out during the quarter.
Echo Street Capital Management sold 3,819 Haemonetics shares in Q3 2023, an estimated $325K.
Echo Street Capital Management first reported a position in Haemonetics in Q1 2021 and held it in 4 quarters.
Echo Street Capital Management's Haemonetics position peaked at $809K in Q4 2022.
296 funds tracked by Wall St. Rank held Haemonetics as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.